• Title of article

    Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques

  • Author/Authors

    Valentin، نويسنده , , Antonio and McKinnon، نويسنده , , Katherine and Li، نويسنده , , Jinyao and Rosati، نويسنده , , Margherita and Kulkarni، نويسنده , , Viraj and Pilkington، نويسنده , , Guy R. and Bear، نويسنده , , Jenifer and Alicea، نويسنده , , Candido and Vargas-Inchaustegui، نويسنده , , Diego A. and Jean Patterson، نويسنده , , L. and Pegu، نويسنده , , Poonam and Liyanage، نويسنده , , Namal ، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2014
  • Pages
    17
  • From page
    91
  • To page
    107
  • Abstract
    To identify the most promising vaccine candidates for combinatorial strategies, we compared five SIV vaccine platforms including recombinant canary pox virus ALVAC, replication-competent adenovirus type 5 host range mutant RepAd, DNA, modified vaccinia Ankara (MVA), peptides and protein in distinct combinations. Three regimens used viral vectors (prime or boost) and two regimens used plasmid DNA. Analysis at necropsy showed that the DNA-based vaccine regimens elicited significantly higher cellular responses against Gag and Env than any of the other vaccine platforms. The T cell responses induced by most vaccine regimens disseminated systemically into secondary lymphoid tissues (lymph nodes, spleen) and effector anatomical sites (including liver, vaginal tissue), indicative of their role in viral containment at the portal of entry. The cellular and reported humoral immune response data suggest that combination of DNA and viral vectors elicits a balanced immunity with strong and durable responses able to disseminate into relevant mucosal sites.
  • Keywords
    Protein , Cellular immune response , Prime-boost vaccination , DNA , Pox virus ALVAC MVA
  • Journal title
    Clinical Immunology
  • Serial Year
    2014
  • Journal title
    Clinical Immunology
  • Record number

    1857093